Literature DB >> 6948765

Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.

E W Fleischman, E L Prigogina, M A Volkova, M A Frenkel, N A Zakhartchenko, L N Konstantinova, G P Puchkova, S A Balakirev.   

Abstract

Results of chromosome studies of blood and bone marrow cells from 101 patients with Ph1 positive chronic myeloid leukemia (CML) confirm the assumptions that clinical and morphologic manifestations of the disease correlate with karyotype peculiarities of leukemia cells. Several variants of the clinical course of CML may be distinguished. One is the variant with a short chronic phase and a comparatively long terminal phase. In blastic crisis the blast cells are peroxidase negative and do not possess cytoplasmic inclusions. Acute transformation occurs without any additional chromosome damage. The second, more common form is less severe because of longer chronic phase but it has a short and grave acute stage. The blast cells present definite signs of myeloid differentiation, they have basophilic or neutrophilic cytoplasmic granules and are peroxidase positive. Marker i(17q) often combined with trisomy 8 is a characteristic chromosome abnormality in the terminal stage of this variant. The third type has an extremely long chronic phase but ends in a rapidly progressing severe and resistant to therapy "lymphoid" blastic crisis. Blast cells have typical "lymphoid" morphology, they are peroxidase negative and contain granular PAS positive substance. Various additional chromosome changes appear in the terminal stage. Future studies of a larger series of patients may possibly reveal more CML variants.

Entities:  

Mesh:

Year:  1981        PMID: 6948765     DOI: 10.1007/bf00294925

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  A case of chronic myeloid leukaemia with a 45-chromosome cell-line in the blood.

Authors:  N B ATKIN; M C TAYLOR
Journal:  Cytogenetics       Date:  1962

2.  Chromosome banding studies in Philadelphia chromosome positive myeloid leukaemia.

Authors:  S D Lawler; F O'Malley; D S Lobb
Journal:  Scand J Haematol       Date:  1976-07

3.  Chromosomal mosaicism associated with prolonged remission in chronic myelogenous leukemia.

Authors:  D W Golde; N L Bersch; R S Sparkes
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

4.  G banding in cytogenetic study of hemoblastoses.

Authors:  E W Fleischman; E L Prigogina
Journal:  Humangenetik       Date:  1975

Review 5.  Cytogenetics of experimental neoplasms and non-random chromosome correlations in man.

Authors:  F Mitelman
Journal:  Clin Haematol       Date:  1980-02

6.  The missing Y chromosome and human leukaemia.

Authors:  A A Sandberg; M Sakurai
Journal:  Lancet       Date:  1973-02-17       Impact factor: 79.321

7.  Identity of the abnormal F-group chromosome associated with polycythaemia vera.

Authors:  B R Reeves; D S Lobb; S D Lawler
Journal:  Humangenetik       Date:  1972

8.  Males with XO Ph1-positive cells: a cytogenetic and clinical subgroup of chronic myelogenous leukaemia?

Authors:  B Pedersen
Journal:  Acta Pathol Microbiol Scand       Date:  1968

9.  Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations.

Authors:  A Hagemeijer; E M Smit; B Löwenberg; J Abels
Journal:  Blood       Date:  1979-01       Impact factor: 22.113

10.  Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.

Authors:  E L Prigogina; E W Fleischman; M A Volkova; M A Frenkel
Journal:  Hum Genet       Date:  1978-03-17       Impact factor: 4.132

View more
  6 in total

1.  Acute lymphoblastic leukemia with t(1;9;22)(q32;q34;q11).

Authors:  Shin Fujisawa; Heiwa Kanamori; Maki Takabayashi; Masatsugu Tanaka; Satoshi Yamaji; Naoto Tomita; Katsumichi Fujimaki; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

2.  The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.

Authors:  H Ahuja; M Bar-Eli; Z Arlin; S Advani; S L Allen; J Goldman; D Snyder; A Foti; M Cline
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Chromosome abnormalities in chronic myeloid leukemia in children.

Authors:  G P Puchkova; E L Prigogina; E W Fleischmann; T S Drosdova; S A Mayakova; I S Peterson
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 4.  Karyotypic progression in human tumors.

Authors:  S R Wolman
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.

Authors:  C Cameron Yin; Lynne V Abruzzo; Xiaoyan Qiu; Effrosyni Apostolidou; Jorge E Cortes; L Jeffrey Medeiros; Gary Lu
Journal:  Cancer Genet Cytogenet       Date:  2009-07

6.  Prognostic significance of isochromosome 17q in hematologic malignancies.

Authors:  Dorota Koczkodaj; Justyna Muzyka-Kasietczuk; Sylwia Chocholska; Monika Podhorecka
Journal:  Oncotarget       Date:  2021-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.